Position in AMGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$19,697,155
+$1,451,270 QoQ
Shares Held
54,394
+4.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#384
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. AMGN ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,876,785 | $723,914,175 | |
| 2 | LLY |
ELI LILLY & Co
|
425,688 | $510,582,998 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,664,909 | $213,940,806 | |
| 4 | JNJ |
Johnson & Johnson
|
688,542 | $174,869,011 | |
| 5 | NVO |
Novo Nordisk A S
|
2,924,500 | $140,200,529 | |
| 6 | AMGN |
Amgen Inc
This page
|
54,394 | $19,697,155 | |
| 7 | PFE |
Pfizer Inc
|
233,339 | $5,618,802 | |
| 8 | NVS |
Novartis AG
|
28,162 | $4,413,548 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,697,155 | 54,394 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $18,245,885 | 51,857 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,116,676 | 52,295 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,619,371 | 51,805 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,559,684 | 52,146 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,571,826 | 33,933 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $8,553,422 | 32,817 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,927,010 | 24,602 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,549,416 | 24,162 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,050,851 | 24,799 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,191,859 | 24,970 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $6,927,020 | 25,774 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $5,844,454 | 26,324 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,358,025 | 26,300 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $6,471,186 | 24,639 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,570,535 | 24,714 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $5,982,260 | 24,588 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,245,243 | 25,826 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,370,483 | 23,872 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,119,150 | 14,668 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,581,281 | 18,795 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,008,296 | 20,129 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $7,322,722 | 31,849 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,786,445 | 30,636 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,248,685 | 30,733 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $5,156,234 | 25,434 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||